SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -83.3% | 9 | -89.2% | 0.00% | – |
| Q3 2019 | $6,000 | -95.0% | 83 | -89.4% | 0.00% | -100.0% |
| Q2 2019 | $119,000 | +1090.0% | 783 | +789.8% | 0.01% | +500.0% |
| Q1 2019 | $10,000 | -95.3% | 88 | -95.5% | 0.00% | -92.3% |
| Q4 2018 | $215,000 | +46.3% | 1,972 | +112.0% | 0.01% | +85.7% |
| Q3 2018 | $147,000 | +48.5% | 930 | +24.0% | 0.01% | +40.0% |
| Q2 2018 | $99,000 | – | 750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |